设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
SpringerLink电子期刊(4)
Elsevier电子期刊(2)
在“
Elsevier电子期刊
”中,
命中:
2
条,耗时:小于0.01 秒
在所有数据库中总计命中:
6
条
1.
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
作者:
Prof Susanna Hegewisch-Becker
;
MD
a
;
&dagger
;
;
hegewisch@t-online.de" class="auth_mail" title="E-mail the corresponding author
;
Ullrich
Graeven
;
MD
b
;
&dagger
;
;
Christian A Lerchenmü
;
ller
;
MD
c
;
Birgitta Killing
;
MD
d
;
Reinhard Depenbusch
;
MD
e
;
Claus-Christoph Steffens
;
MD
f
;
Prof Salah-Eddin Al-Batran
;
MD
g
;
Prof Thoralf Lange
;
MD
h
;
Georg Dietrich
;
MD
i
;
Prof Jan Stoehlmacher
;
MD
j
;
Prof Andrea Tannapfel
;
MD
k
;
Prof Anke Reinacher-Schick
;
MD
l
;
Julia Quidde
;
MD
m
;
Tanja Trarbach
;
MD
n
;
Axel Hinke
;
PhD
o
;
Prof Hans-Joachim Schmoll
;
MD
p
;
Prof Dirk Arnold
;
MD
q
刊名:The Lancet Oncology
出版年:2015
2.
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
作者:
Claus R?del
;
Torsten Liersch
;
Heinz Becker
;
Rainer Fietkau
;
Werner Hohenberger
;
Torsten Hothorn
;
Ullrich
Graeven
;
Dirk Arnold
;
Marga Lang-Welzenbach
;
Hans-Rudolf Raab
;
Heiko S¨¹lberg
;
Christian Wittekind
;
Sergej Potapov
;
Ludger Staib
;
Clemens Hess
;
Karin Weigang-K?hler
;
Gerhard G Grabenbauer
;
Hans Hoffmanns
;
Fritz Lindemann
;
Anke Schlenska-Lange
;
et al.
刊名:Lancet Oncology
出版年:2012
1
按检索点细分(2)
作者(2)
按出版年细分(2)
2015年(1)
2012年(1)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.